Patents by Inventor Craig C. Garner

Craig C. Garner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PHARMACOLOGICAL TREATMENT OF COGNITIVE IMPAIRMENT
    Publication number: 20190209520
    Abstract: Methods for treating an individual to improve cognitive function are provided. In the subject methods, an effective amount of a noncompetitive GABAA ionophore blocker is administered to the individual, resulting in an improvement in cognitive function of the host. The subject methods find use in a variety of different applications.
    Type: Application
    Filed: December 3, 2018
    Publication date: July 11, 2019
    Inventors: Craig C. Garner, Fabian J. Fernandez
  • Pharmacological treatment of cognitive impairment
    Patent number: 10172825
    Abstract: Methods for treating an individual to improve cognitive function are provided. In the subject methods, an effective amount of a noncompetitive GABAA ionophore blocker is administered to the individual, resulting in an improvement in cognitive function of the host. The subject methods find use in a variety of different applications.
    Type: Grant
    Filed: April 2, 2014
    Date of Patent: January 8, 2019
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Craig C. Garner, Fabian J. Fernandez
  • Cognitive function
    Patent number: 9789119
    Abstract: Provided herein are methods, drug formulations, and dosing regimens for improving cognitive function in a normal or cognitively impaired subject. For instance, methods provided herein comprise administering a GABAA receptor antagonist so that peak concentration of the GABAA receptor antagonist occurs when the subject is asleep.
    Type: Grant
    Filed: January 30, 2015
    Date of Patent: October 17, 2017
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Craig C. Garner, H Craig Heller, Damien Colas, Daniel Z. Wetmore
  • COGNITIVE FUNCTION
    Publication number: 20150246054
    Abstract: Provided herein are methods, drug formulations, and dosing regimens for improving cognitive function in a normal or cognitively impaired subject. For instance, methods provided herein comprise administering a GABAA receptor antagonist so that peak concentration of the GABAA receptor antagonist occurs when the subject is asleep.
    Type: Application
    Filed: January 30, 2015
    Publication date: September 3, 2015
    Inventors: Craig C. Garner, H Craig Heller, Damien Colas, Daniel Z. Wetmore
  • Methods for improving cognitive function
    Patent number: 8946206
    Abstract: Provided herein are methods, drug formulations, and dosing regimens for improving cognitive function in a normal or cognitively impaired subject. For instance, methods provided herein comprise administering a GABAA receptor antagonist so that peak concentration of the GABAA receptor antagonist occurs when the subject is asleep.
    Type: Grant
    Filed: December 15, 2011
    Date of Patent: February 3, 2015
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Craig C. Garner, H. Craig Heller, Damien Colas, Daniel Z. Wetmore
  • PHARMACOLOGICAL TREATMENT OF COGNITIVE IMPAIRMENT
    Publication number: 20140296210
    Abstract: Methods for treating an individual to improve cognitive function are provided. In the subject methods, an effective amount of a noncompetitive GABAA ionophore blocker is administered to the individual, resulting in an improvement in cognitive function of the host. The subject methods find use in a variety of different applications.
    Type: Application
    Filed: April 2, 2014
    Publication date: October 2, 2014
    Applicant: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Craig C. Garner, Fabian J. Fernandez
  • Pharmacological treatment of cognitive impairment
    Patent number: 8729067
    Abstract: Methods for treating an individual to improve cognitive function are provided. In the subject methods, an effective amount of a noncompetitive GABAA ionophore blocker is administered to the individual, resulting in an improvement in cognitive function of the host. The subject methods find use in a variety of different applications.
    Type: Grant
    Filed: May 22, 2007
    Date of Patent: May 20, 2014
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Craig C. Garner, Fabian J. Fernandez
  • Cognitive Function
    Publication number: 20120157445
    Abstract: Provided herein are methods, drug formulations, and dosing regimens for improving cognitive function in a normal or cognitively impaired subject. For instance, methods provided herein comprise administering a GABAA receptor antagonist so that peak concentration of the GABAA receptor antagonist occurs when the subject is asleep.
    Type: Application
    Filed: December 15, 2011
    Publication date: June 21, 2012
    Applicant: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Craig C. Garner, H. Craig Heller, Damien Colas, Daniel Z. Wetmore
  • Chlorotoxin inhibition of cell invasion, cancer metastasis, angiogenesis and tissue remodeling
    Publication number: 20030021810
    Abstract: The present invention provides methods of treating individuals having a pathophysiological conditions that involve the activity of matrix metalloproteinase-2/pro-MMP2 system, comprising the step of: administering to said individual a pharmaceutical composition comprising a pharmaceutically effective dose of chlorotoxin and a pharmaceutically acceptable carrier.
    Type: Application
    Filed: June 26, 2002
    Publication date: January 30, 2003
    Inventors: Harald W. Sontheimer, Craig C. Garner, Jessy Deshane